Acquisition of rifabutin resistance by a rifampicin resistant mutant of <it>Mycobacterium tuberculosis </it>involves an unusual spectrum of mutations and elevated frequency
Oskam Linda, Brown Tim J, Bergval Indra L and 3 more
Annals of Clinical Microbiology and Antimicrobials · 2005
doi:10.1186/1476-0711-4-9 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p>Mutations in a small region of the <it>rpoB </it>gene are responsible for most rifamycin resistance in <it>Mycobacterium tuberculosis</it>. In this study we have sequentially generated resistant strains to first rifampicin and then rifabutin. Portions of the <it>rpoB </it>gene were sequenced from 131 randomly selected mutants. Second round selection resulted in a changed frequency of specific mutations.</p> <p>Methods</p> <p><it>Mycobacterium tuberculosis </it>(strain Mtb72) rifamycin resistant mutants were selected <it>in vitro </it>with either rifampicin or rifabutin. One mutant R190 (<it>rpoB </it>S522L) selected with rifampicin had a rifampicin MIC of 32 μg/ml but remained sensitive to rifabutin (MIC<0.8 μg/ml). This mutant was subjected to a second round of selection with rifabutin.</p> <p>Results</p> <p>All 105 first round resistant mutants derived from the parent strain (Mtb72) screened acquired mutations within the 81 bp <it>rpoB </it>hotspot. When the rifampicin resistant but rifabutin sensitive S522L mutant was subjected to a second round of selection, single additional <it>rpoB </it>mutations were identified in 24 (92%) of 26 second round mutants studied, but 14 (54%) of these strains contained mutations outside the 81 bp hotspot (codons 144, 146, 148, 505). Additionally, spontaneous rifabutin resistant mutants were produced at >10 times the frequency by the S522L mutant than the parent strain.</p> <p>Conclusion</p> <p>First round selection of mutation S522L with rifampicin increased the frequency and changed the spectrum of mutations identified after selection with rifabutin.</p>
Abstract licence: CC BY-NC-ND
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.